Mondo 10 Novembre 2015 15:43

International healthcare

OECD report: how is the world?

Let’ s start with the good news. As described in the OECD report on Healthcare, life expectancy continues to increase worldwide, with a rate of about 3-4 months more per year. Japan stands at the top of the list (83,4 years), followed immediately by the European protagonists of longevity: Spain (83,2), Switzerland (82,9), Italy (82,8) and France (82,3). Concerning access to care, about 20% of health expenditure comes from the citizens’ own pockets. This percentage goes below 10% in France and in the United Kingdom only. Moreover, the number of nurses and doctors has increased since 2000, especially in countries such as the UK where the number of this kind of specialists was lower. The OECD report highlights the paradox of Italy, the Mediterranean diet birthplace and, at the same time, the country where overweight children and obesity rates are among the highest in the world. This figure ranks our country in the fifth place amongst all organization members, right behind Greece, UK, US and New Zealand. Italy scored another first place not to be proud of: the very high percentage of cesarean sections (36,1%), over and above the OECD average (27,6%) and pretty far from French (20,8%) and British (23%) standards.

Articoli correlati
Life expectancy and prophylaxis, Italy «Cinderella of the UE»
The Osservasalute report in 2015 has revealed some surprises, some of which not positive for our country. Apart from a slight decrease in life expectancy, which fell from 80.3 for men and 85 for women in 2014 to 84.7 years for men and 80.1 for women, Italy allocates just 4.1 per cent of total health […]
GLI ARTICOLI PIU’ LETTI
Politica

Liste di attesa addio? La risposta del Consiglio dei Ministri in due provvedimenti

Ieri il Consiglio dei ministri, su proposta del Presidente, Giorgia Meloni, e del Ministro della salute, Orazio Schillaci, ha approvato due provvedimenti, un decreto-legge e un disegno di legge, che i...
Salute

Tumori: boom di casi nei paesi occidentali. Cinieri (Aiom): “Prevenzione attiva per ridurre carico della malattia”

Nel 2024 negli USA, per la prima volta nella storia, si supera la soglia di 2 milioni di casi di tumore. Una crescita importante, comune a tutti i Paesi occidentali. Per Saverio Cinieri, presidente di...
Salute

Tumore del polmone: per osimertinib e durvalumab ottimi risultati negli studi LAURA e ADRIATIC al Congresso ASCO

Nello studio LAURA osimertinib ha ridotto il rischio di progressione di malattia o di morte dell’84% nel tumore del polmone non a piccole cellule di Stadio III. Nello studio ADRIATIC, invece, du...